drugset / Trial / NCT04786795
MITE in the Treatment of Dyspepsia After Cholecystectomy
RandomizedParallel-groupOpen-labelTreatment
Summary
To confirm the clinical efficacy of Compound Azintamide Enteric-coated Tablets in the treatment of patients with dyspepsia after cholecystectomy (such as abdominal distension, abdominal pain/abdominal discomfort, diarrhea/fatty stool, early satiety, belching, loss of appetite, etc.) by comparing with positive control drug, to observe its safety, and to evaluate the quality of life of subjects before and after treatment
Timeline
- Start
- 2021-03-01
- Primary completion
- 2022-02-01
- Completion
- 2022-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Azintamide | Small molecule | — | — |
| Comparator | Oryz-Aspergillus Enzyme | Unknown | — | — |
| Comparator | Pancrelipase | Protein / enzyme biologic | — | — |
| Comparator | Ursodeoxycholic Acid | Small molecule | — | — |